Synjardy® XR (empagliflozin and metformin hydrochloride extended-release Tablets)

DRUG2 trials

Sponsors

Humanis Saglık Anonim Sirketi

Conditions

Type 2 Diabetes Mellitus (T2DM)

Phase 1

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

CompletedNCT07266766

Humanis Saglık Anonim SirketiType 2 Diabetes Mellitus (T2DM)

Start: 2025-08-05End: 2025-10-06Updated: 2025-12-05

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

CompletedNCT07372118

Humanis Saglık Anonim SirketiType 2 Diabetes Mellitus (T2DM)

Start: 2025-09-27End: 2026-01-07Updated: 2026-01-28